Angiotensin II (AngII) receptors couple to a multitude of different types of G-proteins resulting in activation of numerous signaling pathways. In this study we examined the consequences of this promiscuous G-protein coupling on secretion. Chromaffin cells were voltage-clamped at Ϫ80 mV in perforated-patch configuration, and Ca 2ϩ -dependent exocytosis was evoked with brief voltage steps to ϩ20 mV. Vesicle fusion was monitored by changes in membrane capacitance (⌬C m ), and released catecholamine was detected with single-cell amperometry. Ca ] i ) with fura-2 AM.
Angiotensin II (AngII) receptors couple to a multitude of different types of G-proteins resulting in activation of numerous signaling pathways. In this study we examined the consequences of this promiscuous G-protein coupling on secretion. Chromaffin cells were voltage-clamped at Ϫ80 mV in perforated-patch configuration, and Ca 2ϩ -dependent exocytosis was evoked with brief voltage steps to ϩ20 mV. Vesicle fusion was monitored by changes in membrane capacitance (⌬C m ), and released catecholamine was detected with single-cell amperometry. Ca 2ϩ signaling was studied by recording voltage-dependent Ca 2ϩ currents (I Ca ) and by measuring intracellular Ca 2ϩ ([Ca 2ϩ ] i ) with fura-2 AM.
AngII inhibited I Ca (IC 50 ϭ 0.3 nM) in a voltage-dependent, pertussis toxin (PTX)-sensitive manner consistent with G i/oprotein coupling to Ca 2ϩ channels. ⌬C m was modulated bidirectionally; subnanomolar AngII inhibited depolarizationevoked exocytosis, whereas higher concentrations, in spite of I Ca inhibition, potentiated ⌬C m fivefold (EC 50 ϭ 3.4 nM). Potentiation of exocytosis by AngII involved activation of phospholipase C (PLC) and Ca 2ϩ mobilization from internal stores. PTX treatment did not affect AngII-dependent Ca 2ϩ mobilization or facilitation of exocytosis. However, protein kinase C (PKC) inhibitors decreased the facilitatory effects but not the inhibitory effects of AngII on stimulus-secretion coupling. The AngII type 1 receptor (AT1R) antagonist losartan blocked both inhibition and facilitation of secretion by AngII. The results of this study show that activation of multiple types of G-proteins and transduction pathways by a single neuromodulator acting through one receptor type can produce concentration-dependent, bidirectional regulation of exocytosis.
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Modulation of neurotransmitter release and hormone secretion via activation of G-protein-coupled receptors (GPCRs) is a key element in information processing within an organism. To understand how secretion is modulated, it is important to characterize the mechanisms underlying GPCR regulation of ion channels, C a 2ϩ signaling, and the exocytotic machinery. Given the divergence and convergence of downstream signaling cascades modulated by G-protein subunits (Gudermann et al., 1996) , the effects of a single neuromodulator on regulated exocytosis may be complex and variable depending on stimulus conditions.
GPCRs have been postulated to modulate neurotransmission either through an effect on membrane excitability and Ca 2ϩ signaling or via second messenger-mediated changes in the activity of the proteins controlling exocytosis (Wu and Saggau, 1997; Miller, 1998) . The inaccessibility of most mammalian nerve terminals makes direct investigation of stimulus-secretion coupling and its modulation difficult. However, such studies can be performed on neuroendocrine cells where the Ca 2ϩ signals regulating exocytosis may be controlled and monitored and vesicle fusion assessed directly using membrane capacitance measurements and amperometry (Neher, 1998) . With such an approach, previous studies have shown that activity-dependent changes in exocytosis are mediated by Ca 2ϩ and protein kinase C (PKC) (Smith et al., 1998) . The aim of this study was to examine the mechanism(s) underlying GPCR modulation of exocytosis. We studied the effects of angiotensin II (AngII) on secretion because (1) it is well established that this peptide modulates catecholamine release from neurons and chromaffin cells (Feldberg and Lewis, 1964; Bottari et al., 1993) , and (2) AngII type 1 receptors (AT1Rs) are coupled to a plethora of different types of G-protein (Richards et al., 1999) . How AT1R signaling pathways modulate exocytosis is unknown.
We combined voltage-clamp, ⌬C m , ratiometric fluorescence, and electrochemical techniques on single cells to examine directly the effects of AngII on stimulus-secretion coupling in adrenal chromaffin cells. We show that subnanomolar AngII inhibits Ca 2ϩ influx and vesicle fusion via a G i /o -dependent pathway. At higher concentrations, the inhibitory effects of AngII are surmounted, producing an increase in exocytosis. The facilitatory effects of AngII are pertussis toxin (PTX)-insensitive and are associated with activation of phospholipase C (PLC), storedependent rise in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ), and activation of PKC. The results of this study show that GPCR regulation of multiple signaling pathways may produce antagonistic modulation of neurotransmitter release.
Some preliminary data have been published previously in abstract form (Teschemacher et al., 1998) . 2ϩ influx was quantified by integrating I C a , omitting the first 2 msec, which were contaminated by Na ϩ currents. ⌬C m was measured relative to a 100 fF calibration signal that was routinely switched in and out of the circuit during the course of a recording. All experiments were performed at ambient temperature (21-25°C).
[Ca 2ϩ ] i measurements. C ells were preloaded with C a 2ϩ indicator by incubating for 25 min at 37°C in DM EM medium containing 5 M f ura-2 AM (Molecular Probes) followed by washing with fresh DM EM and incubating for a f urther 15 min. Chromaffin cells were alternately illuminated at 340 and 380 nm using a monochromator (TIL L Photonics, Martinsried, Germany) controlled by the C m data acquisition software. Emission Ͼ430 nm was collected with a photomultiplier tube (TIL L Photonics) and sampled every 12 msec. Data were stored on PC and ratios of 340/380 nm were calculated off-line (Axobasic-written software; E xcel, Microsoft). C alibration of f ura-2 AM was performed by the method of Grynkiewicz et al. (1985) . R min and R max and S f2 /S b2 were obtained by permeabilizing chromaffin cells with 10 M ionomycin or 3 M digitonin in the presence of 10 mM EGTA or 20 mM Ca 2ϩ , respectively.
Electrochemical catecholamine detection. C atecholamine release was detected by single-cell amperometry according to the method described by Schulte and Chow (1998) . C arbon fiber probes (5 M diameter; AL A Scientific Instruments, New York, N Y) were charged to ϩ800 mV and brought into contact with the plasma membrane of chromaffin cells that were voltage-clamped in perforated-patch-clamp configuration. Currents were measured and low-pass-filtered at 3 kHz using a VA-10 amplifier (npi electronics, Hamm, Germany) and digitized at 5 kHz with commercial software (pCL AM P, Axon Instruments) running on a second Pentium computer equipped with a Digidata 1200 data acquisition board (Axon Instruments). At the end of each experiment, the quality of the carbon fiber electrode and the ability of a chromaffin cell to produce amperometric signals were verified by application of high concentrations of nicotine or by rupturing the cell membrane. Amperometric events were analyzed by software developed by S. Kasparov (University of Bristol). Individual events with a rapid rise-time (Ͻ0.5 pA /msec) and integrated charge Ͼ30 fC were automatically detected by the software and summed for the duration (25 sec) of the corresponding capacitance trace.
Drug application. All drugs were added to the superf using external solution. Because of the prominent desensitization of responses at Ͼ1 nM AngII, unless stated otherwise, only one agonist application was made per coverslip. The specific nonpeptide AngII receptor antagonists losartan (kind donation from Merck, Sharp & Dohme, Hertfordshire, UK) and PD 123,319 (RBI, Natick, M A) were applied for 2 min before and during AngII treatment. All drugs were made up as stock solutions and stored in aliquots at Ϫ20°C. A fresh aliquot was used for each experiment and diluted at least 1000-fold. U-73122, U-73443 (Biomol, Plymouth Meeting, PA), C alphostin C (Biomol), and bisindolylmaleimide (BIS; C albiochem, Nottingham, UK) were solved in DMSO. C yclopiazonic acid (C PA; C albiochem) was dissolved in chloroform.
Because of the transient nature of responses to AngII, percentile changes of parameters under investigation were obtained by relating maximal deflections after drug application to the average of four measurements immediately preceding treatment. All results are presented as mean Ϯ SEM. Unless stated otherwise in the text, changes were tested with Student's paired t test. Statistical significance was accepted at a level of p Ͻ 0.05. A total of 135 chromaffin cells from 35 cultures were used in this study. Of these, seven recordings from three cultures were excluded because they failed to show any response to AngII.
RESULTS

AngII inhibition of I Ca in chromaffin cells
Ca 2ϩ entry through voltage-operated Ca 2ϩ channels (VOCCs) regulates depolarization-evoked exocytosis in neurons and chromaffin cells. GPCRs are known to modulate VOCCs either through a well characterized, ubiquitous membrane-delimited pathway or through an undefined second-messenger mediated pathway(s) (Hille, 1994; Dolphin, 1998) . To gain insight into the mechanisms underlying modulation of exocytosis by AT1Rs, in our first series of experiments we investigated the effect of AngII on VOCCs in chromaffin cells. All of our studies were performed using the perforated-patch configuration to avoid dialysis of agonist-induced changes in diffusable second messengers and rundown of I C a and exocytosis . Furthermore, we used Ca 2ϩ as the divalent cation to retain normal Ca 2ϩ homeostasis pathways and to maintain the function of Ca 2ϩ -dependent proteins important in cell signaling and exocytosis .
Superfusion of AngII for 2-3 min produced a reversible inhibition of I C a ( Fig. 1 A, B) . The concentration-response curve for AngII inhibition of Ca 2ϩ entry (determined by integration of I C a ; see Materials and Methods) had an IC 50 of 0.28 nM, a maximum of 39 Ϯ 3% at 10 nM, and a Hill slope of 1.18 (Fig. 1C) . At 100 nM, the inhibition of I C a was reduced to 30 Ϯ 3% (n ϭ 16). In eight cells, a second application of 100 nM AngII after 10 min wash failed to inhibit I C a , suggesting that AT1Rs in chromaffin cells undergo rapid and profound desensitization similar to that reported previously (Wang et al., 1994; Oppermann et al., 1996) . Characterization of this desensitization is beyond the scope of the present study and was not pursued further; in all subsequent experiments, responses to only the first application of AngII are reported.
Inhibition of neuronal VOCCs by G␤␥-subunits via a "membrane-delimited" pathway is voltage dependent and typified by a slowing of activation kinetics and time-dependent recovery during depolarization (Dolphin, 1998) . The inhibition of I C a produced by 1 nM AngII in chromaffin cells was found to decrease from 36.0 Ϯ 3.2% at the peak to 25.6 Ϯ 2.3% during a 30 msec depolarization to ϩ20 mV (n ϭ 5). Application of a large depolarizing prepulse to ϩ120 mV for 40 msec before the test pulse reduced the AngII inhibition of I C a from 40.8 Ϯ 3.6 to 2.6 Ϯ 4.7% (10 nM; n ϭ 4) (Fig. 1 D) . Treatment of cells with PTX abolished the effects of AngII on I C a (see Fig. 8C ). No evidence for a voltage-independent inhibition of I C a by AngII as described for sympathetic neurons (Shapiro et al., 1994) nor any facilitation of I C a as described for sensory neurons (Bacal and Kunze, 1994) was observed in chromaffin cells. The subtype of receptor mediating the effects of AngII on VOCCs was determined using specific antagonists (Hunyady et al., 1996) . The AT1R antagonist losartan (10 M) abolished I C a inhibition by AngII (100 nM, n ϭ 8), whereas the specific AngII type 2 receptor antagonist PD123,319 (10 M, n ϭ 5) did not (see Fig. 8C ). Taken together, these results show that in chromaffin cells AngII acts via a G i /o -protein coupled to AT1Rs to inhibit VOCCs through a voltage-dependent mechanism.
Bidirectional, concentration-dependent modulation of exocytosis by AngII
C m is proportional to cell surface area and is increasingly used as a method for monitoring exocytosis with exquisite resolution. Fusion and endocytosis of vesicles are observed as increases and decreases in C m , respectively. To examine the effects of AngII on secretion, cells were stimulated every 25 sec with voltage steps to ϩ20 mV from a holding potential of Ϫ80 mV. Before drug application, the step duration was adjusted to between 30 and 60 msec to achieve a reproducible ⌬C m of 50 -100 fF. This stimulus paradigm avoids depletion of the readily releasable pool (RRP) (Smith et al., 1998) and activity-dependent changes in exocytotic efficiency (Engisch et al., 1997) . Application of 1 nM AngII produced concomitant inhibition of Ca 2ϩ entry (30 Ϯ 2%) and ⌬C m (42 Ϯ 9%; n ϭ 6) ( Fig. 2 A) ; however, the inhibition of exocytosis by AngII did not produce a significant change in exocytotic efficiency (⌬C m /͐ Ca 2ϩ ions) (92 Ϯ 6% of control, n ϭ 6), suggesting that at this concentration AngII does not alter the Ca 2ϩ dependence of exocytosis. At higher AngII concentrations (100 nM), C m increases were no longer inhibited but potentiated to 524 Ϯ 118% of control (n ϭ 11) despite inhibition of Ca 2ϩ entry by 31 Ϯ 3% (Fig. 2 B, C) . The exocytotic efficiency was facilitated to 819 Ϯ 291% of control (n ϭ 11) ( Table 1 ). The facilitatory effect of AngII on secretion was transient, and its onset either coincided with (n ϭ 8) or was delayed by up to 1 min with respect to I C a inhibition (n ϭ 3) (Fig. 2C ). At the intermediate concentration of 10 nM, the effect of AngII on ⌬C m was highly variable from cell to cell, resulting in either inhibition (40% of cells) or potentiation (60% of cells) (Fig. 2 D) .
Amperometric evidence for catecholamine secretion
Previous studies have shown that AngII increases catecholamine release from populations of chromaffin cells , and it is likely that the ⌬C m increases observed in this study result from fusion of catecholamine-containing vesicles. To confirm this and to obtain some indirect spatial information on the effects of AngII on stimulus-evoked exocytosis, we combined C m measurements with single-cell amperometry. The carbon fiber electrodes that were used had tip diameters of ϳ5 m so that single vesicle release events of catecholamine were only detected when the fiber was in close proximity to a release site (Robinson et al., 1995) . We had no means of determining where the release sites were and found empirically that the probability of obtaining synchronous amperometric spikes and depolarization-evoked ⌬C m under control conditions was low. Thus for a 100 fF C m increase, the average integrated charge was 4.4 Ϯ 3.2 pC (n ϭ 3 cells, 10 depolarizations per cell). Increasing stimulus strength to evoke a ⌬C m of 300 -400 fF did not increase the number of events detected with amperometry, consistent with previous reports that secretion remains highly localized (Schroeder et al., 1994; Robinson et al., 1995) . In the presence of AngII (100 nM), previously silent sites became active, with both asynchronous unitary events and synchronous release events being observed (Fig. 3 A, C) . The mean Figure 1 . AngII inhibition of I Ca in bovine adrenal chromaffin cells. A, Superimposed current traces evoked by 60 msec voltage steps to ϩ20 mV in a cell clamped at Ϫ80 mV in perforated-patch configuration. Currents were recorded immediately before (control) and during superfusion of AngII (1 nM) as indicated. The transient current observed during the first 3 msec of the voltage step is attributable to activation of Na ϩ channels; this is followed by a more sustained inward current resulting from activation of VOCCs. amperometric charge recorded in the presence of AngII was 32 Ϯ 17 pC, which represents a 1051 Ϯ 565% increase over control (Fig. 3B) . These results confirm that the potentiation of ⌬C m observed after application of high concentrations of AngII are caused by increased exocytosis of catecholamine-containing vesicles and furthermore suggest that AngII increases the number of active release sites.
Ca
2؉ mobilization is required for AngII-dependent facilitation of exocytosis
Previous studies have shown that AngII activates PLC, leading to formation of inositol phosphates and a rise in [Ca 2ϩ ] i in bovine chromaffin cells (Plevin and Boarder, 1988; Bunn and Marley, 1989; . To examine the relationship between AngII-induced Ca 2ϩ signaling and stimulus-evoked exocytosis, we combined recording of I C a and ⌬C m with fura-2 AM measurements of [Ca 2ϩ ] i . Under control conditions, the mean basal [Ca 2ϩ ] i in chromaffin cells held at Ϫ80 mV was 218 Ϯ 22 nM (n ϭ 11), which is comparable to that reported in other studies using constant, low-frequency voltage stimulation (Smith et al., 1998) . AngII (100 nM) increased basal [Ca 2ϩ ] i to 502 Ϯ 66 nM (n ϭ 11), corresponding to a mean increase of 235 Ϯ 28%. The rise in [Ca 2ϩ ] i peaked within 30 -60 sec of AngII reaching the cell and subsequently declined despite the continued presence of agonist (Fig. 4 A, B) . In all cells the rise in [Ca 2ϩ ] i induced by 100 nM AngII was associated with a profound but transient facilitation of exocytosis (Fig. 4 A, B) . We observed a strong correlation between the percentage increase in ⌬C m and the percentage increase in [Ca 2ϩ ] i relative to control (R 2 ϭ 0.87) (Fig. 4C ). In contrast, there was a poor correlation (R 2 ϭ 0.29) between the percentage increase in exocytosis and the peak [Ca 2ϩ ] i recorded in the presence of AngII.
In addition to facilitation of stimulus-evoked exocytosis, in 52% of cells examined (n ϭ 21), the rising phase of the [Ca 2ϩ ] i increase produced by AngII was followed by a C m increase, in the absence of voltage stimulation (Fig. 5A ). Because this increase in C m occurred at the holding potential of Ϫ80 mV, we will refer to it as depolarization-independent exocytosis. In cells in which AngII induced depolarization-independent exocytosis, the potentiation of subsequent stimulus-evoked exocytosis was greatest 
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Exocytotic efficiency was determined from the ratio of ⌬C m to integrated Ca 2ϩ entry. To avoid problems with cell-to-cell variability, each cell was used as its own control. Values given represent the mean change in exocytotic efficiency Ϯ SEM produced by a drug for the number of cells given by n. Shifts in exocytotic efficiency represent changes in the Ca 2ϩ dependence of exocytosis caused either by a change in the affinity of the secretory machinery for Ca 2ϩ or a change in the number of vesicles available for release in the RRP. Significant changes are indicated by * (p Ͻ 0.05). The potentiation of exocytosis produced by AngII (100 nM) was associated with a profound increase in exocytotic efficiency. Inhibition of exocytosis by lower concentrations of AngII, however, was not associated with a change in exocytotic efficiency. (range 466 -2681%; n ϭ 7), indicating that depolarizationindependent exocytosis does not deplete the cell of releasable vesicles. Depolarization-independent exocytosis was observed in cells in which (1) the [Ca 2ϩ ] i rise reached significantly higher levels (608 Ϯ 72 nM) than in other cells (398 Ϯ 53 nM; unpaired t test), and (2) the average holding current increased in the presence of AngII from Ϫ8.5 to Ϫ10.5 pA (Fig. 5B) . The small amplitude of this current is consistent with previously characterized store-operated Ca 2ϩ entry currents that trigger voltageindependent exocytosis in chromaffin cells (Fomina and Nowycky, 1999) . After removal of Ca 2ϩ from the external solution for 1.5 min, the rise in [Ca 2ϩ ] i produced by AngII (430 Ϯ 119%, n ϭ 6) or caffeine (50 mM; n ϭ 9) at a concentration shown previously to deplete stores in chromaffin cells (Cheek et al., 1993b) failed to trigger depolarization-independent exocytosis. This is in agreement with previous studies that also found that external Ca 2ϩ was necessary for AngII-induced catecholamine release Cheek et al., 1993a) . Collectively, the results suggest that agonist-stimulated Ca 2ϩ entry across the plasma membrane in addition to Ca 2ϩ release from internal stores is required to trigger vesicle fusion in the absence of membrane depolarization.
To determine the role of Ca 2ϩ released from internal stores in facilitation of exocytosis, cells were treated with CPA (3 M), a blocker of neuronal endoplasmic Ca 2ϩ -ATPases (Sandler and Barbara, 1999) . Before application of AngII, depletion of the stores was ensured and tested with two to three applications of caffeine (50 mM, 1.5 min). Depletion of internal stores abolished the AngII-induced rise in basal [Ca 2ϩ ] i (122 Ϯ 3% control) and reduced the facilitation of stimulus-evoked exocytosis (174 Ϯ 17% of control; n ϭ 3) (Fig. 6, Table 1 ). After washout of CPA and store refilling, reapplication of caffeine increased basal [Ca 2ϩ ] i to 232 Ϯ 12% of control and potentiated stimulus-evoked ⌬C m to 226 Ϯ 93% of control (n ϭ 3) (Fig. 6 ). An equivalent rise in basal [Ca 2ϩ ] i induced by AngII facilitated ⌬C m by ϳ500% (Fig. 4C) , suggesting that increased [Ca 2ϩ ] i was not the only mechanism responsible for facilitation of exocytosis after activation of AngII receptors.
In addition to generating inositol phosphates, activation of PLC by AngII generates the second messenger sn-1,2-diacylglycerol (Tuominen et al., 1993) . The role of PLC in mediating the effects of AngII (100 nM) on stimulus-secretion coupling was examined by treating cells for 7 min with either the PLC inhibitor U-73122 (1 M) or its inactive isomer U-73443 (1 M). In the presence of the active isomer, both the AngII-induced rise in basal [Ca 2ϩ ] i and facilitation of stimulus-evoked exocytosis were significantly decreased to 154 Ϯ 44 and 79 Ϯ 18% of control (n ϭ 5), respectively. By contrast, U-73443 had no significant effects on AngII-induced increases in basal [Ca 2ϩ ] i (282 Ϯ 92%) or on stimulus-evoked exocytosis (627 Ϯ 263%; n ϭ 3) ( Table 1) . These studies support the need for generation of a Ca 2ϩ -mobilizing second messenger and activation of PLC in agonist-induced facilitation of exocytosis.
Role of PKC in AngII-dependent facilitation of stimulus-evoked exocytosis
AngII-stimulated sn-1,2-diacylglycerol production may facilitate exocytosis through activation of PKC and/or Doc2␣-Munc13 interactions (Terbush et al., 1988; Hori et al., 1999) . The role of PKC in mediating the effects of AngII on stimulus-evoked exocytosis was examined by treating cells with either Calphostin C (100 nM for 7 min) or BIS (500 nM Ͼ20 min) before application of AngII. These two inhibitors were selected because of their different modes of action. Calphostin C inhibits PKC and possibly other recently identified signaling molecules by competing with diacylglycerol for the regulatory C1 binding site (Mellor and Parker, 1998) . BIS, on the other hand, at nanomolar concentrations acts as a highly selective competitive inhibitor for the ATPbinding site of PKC (Toullec et al., 1991) . We observed that BIS reduced the potentiation of ⌬C m by AngII from 524 Ϯ 118% (n ϭ 11) to 215 Ϯ 90% (n ϭ 7) (Fig. 7 A, B , Table 1 ), suggesting that PKC is involved in agonist-dependent facilitation of exocytosis. Consistent with this, Calphostin C was found to abolish the AngII-induced potentiation of stimulus-evoked exocytosis (104 Ϯ 36% of control; n ϭ 7) (Fig. 7B, Table 1 ). In contrast to BIS, Calphostin C also attenuated the AngII-induced rise in [Ca 2ϩ ] i (118 Ϯ 17%). We do not believe that the effects of Calphostin C on [Ca 2ϩ ] i were attributable simply to toxicity, because neither Calphostin C nor BIS blocked the AngII inhibition of I C a (Fig.  7C) . Instead, Calphostin C may be depleting stores through an . Exocytosis was evoked at the start of each trace with a 60 msec voltage step to ϩ20 mV from a holding potential of Ϫ80 mV (indicated by the gap in the C m trace; asterisks indicate 100 fF calibration steps). In the absence of the agonist, the voltage stimulus elicited a ⌬C m of 60 fF, but no amperometric spikes were detected. Thirty seconds into AngII application (middle trace), amperometric spikes that were not synchronized with stimulusevoked ⌬C m were observed. A subsequent voltage stimulus evoked a ⌬C m potentiated by 400% (top right) and corresponding large amperometric current response (below). B, Mean data from three experiments similar to those illustrated in A. Data plotted are mean Ϯ SEM integrated amperometric charge recorded over 30 sec intervals for the duration of the experiment. AngII (100 nM) application is indicated by the bar. C, Amperometric response that was recorded in synchrony with the potentiated ⌬C m during application of AngII. Note that several spikes can be distinguished. Data are from the same cell illustrated in A shown on an expanded time scale.
inhibitory effect on diacylglycerol-regulated Ca 2ϩ entry pathways (Hofmann et al., 1999) .
For comparison, in some experiments we used PMA (50 nM) to directly activate diacylglycerol-regulated proteins. In agreement with previous reports, PMA facilitated exocytosis to 442 Ϯ 100% of control (n ϭ 5) but, in contrast to AngII, without significantly affecting I C a (94 Ϯ 3% control) (Fig. 7A, Table 1 ). The facilitatory effects of PMA on ⌬C m were abolished by Calphostin C (n ϭ 5) and reduced by BIS to 228 Ϯ 46% of control (n ϭ 5) (Fig. 7A) . Collectively, the results from these experiments suggest that AngII facilitates depolarization-evoked exocytosis through activation of PLC, raising [Ca 2ϩ ] i and activation of PKC.
AT1Rs couple to multiple G-proteins to produce bimodal regulation of exocytosis
Results from both binding and cloning experiments suggest that bovine chromaffin cells express only a single type of AngII receptor with the pharmacological properties of an AT1R . In heterologous expression systems, AT1Rs have been found to couple to multiple G-proteins (Shibata et al., 1996) . Thus in our final set of experiments we wished to determine whether AT1R activation of multiple G-proteins could produce bimodal regulation of exocytosis. Consistent with this hypothesis, we observed that all of the effects of AngII on stimulus-secretion coupling were blocked by the AT1R antagonist losartan (Fig.  8C-F ) . Furthermore, uncoupling of receptors from G i /o -proteins with PTX abolished the inhibitory effects of AngII on I C a and exocytosis but not the facilitatory effects (Fig. 8) . In PTX-treated cells, the concentration-response curve for AngII modulation of exocytosis became unimodal, and thus the EC 50 for facilitation could be determined and was found to be 3.4 nM (compare Figs.  2 D and 8 B) . Moreover, the maximum facilitation of stimulusevoked ⌬C m observed with 100 nM AngII was increased to 785 Ϯ 246% (n ϭ 7) compared with the 524 Ϯ 118% potentiation observed in untreated cells. These results suggest that AT1Rs in chromaffin cells are coupled via distinct G-proteins to multiple signal transduction cascades to produce opposing effects on I C a , cytosolic [Ca 2ϩ ], and exocytosis.
DISCUSSION
The results of this study show that activation of multiple G-proteins and transduction pathways by a single neuromodulator acting through one receptor type can produce concentrationdependent, bidirectional regulation of exocytosis. Metabotropic glutamate receptors have also been shown to switch between facilitation and inhibition of synaptic transmission; however, in this case coupling of the receptor to G i /o -and G q -proteins is regulated by desensitization (Rodriguez-Moreno et al., 1998 ). This does not appear to be the mechanism underlying AngII bimodal regulation of secretion, because the inhibitory effects of the G i /o -protein-coupled receptor on VOCCs and the facilitatory effects on exocytosis mediated by the G q -protein-coupled receptor could be seen simultaneously with high concentrations of agonist. Thus it would appear that coupling of a single type of receptor to different signal transduction pathways not only serves to coordinate short-term and long-term changes in neuronal function, but may also allow neurons to adapt their secretory output in response to fluctuating levels of agonist.
Transduction pathway mediating AT1R inhibition of depolarization-dependent exocytosis
Inhibition of transmitter release by other G-protein-coupled receptors is generally thought to involve either changes in membrane excitability and Ca 2ϩ signaling or a direct effect on some component of the release machinery (Hille, 1994; Wu and Saggau, 1997; Miller, 1998) . In this study we showed that low concentrations of AngII induced a parallel inhibition of I C a and exocytosis. The inhibition of I C a displayed the characteristic voltage sensitivity commonly associated with GPCR inhibition of neuronal VOCCs by a membrane-delimited pathway involving G␤␥-subunits (Dolphin, 1998) . PTX abolished the inhibition of I C a and exocytosis by AngII without affecting AT1R coupling to PLC, Ca 2ϩ mobilization, and facilitation of exocytosis. Inhibition of PKC, on the other hand, did not prevent AngII modulation of I C a . Taken together, the results suggest that G␤␥-subunits from G i /o -coupled AT1Rs inhibit I C a in chromaffin cells, but G␤␥-subunits associated with Ca 2ϩ -mobilizing AT1Rs do not. Our results are consistent with the observation that ␤␥-subunits associated with non-PTX-sensitive G-proteins have a low affinity for VOCCs (Garcia et al., 1998) . Further restraints on the transduction pathway involved in inhibition of stimulus-evoked exocytosis may result from compartmentalization of the G i /o -and G q /11 -coupled AT1Rs to different poles of the cell, with only the former being in a position to regulate VOCCs through the membranedelimited pathway. GPCRs and voltage-dependent evoked rises in [Ca 2ϩ ] i have indeed been shown to occur in discreet areas of the cell (Robinson et al., 1996) .
There are two Ca 2ϩ -sensitive processes that contribute to exocytosis and could therefore be affected by inhibition of I C a : a high-affinity step that regulates the number of vesicles in the RRP and a low-affinity step that controls vesicle fusion (Neher, 1998) . The size of the RRP is directly correlated to [Ca 2ϩ ] i (Heinemann et al., 1993) , whereas depolarization-evoked vesicle fusion is determined by the integrated Ca 2ϩ entry through VOCCs (Engisch and Nowycky, 1996; . At low concentrations, AngII decreased Ca 2ϩ entry through VOCCs and exocytosis without significantly affecting the resting [Ca 2ϩ ] i . Therefore, inhibition of vesicle fusion rather than the filling state of the RRP is the most likely mechanism underlying inhibition of secretion. The fusion machinery itself appeared unaffected by activated G i /o -proteins because exocytotic efficiency was unaffected by low concentrations of AngII. This is consistent with our previous studies in chromaffin cells on another G i /o -protein- coupled receptor and with studies on a central glutamatergic synapse and support the hypothesis that depression of exocytosis observed after activation of PTX-sensitive G-proteins is fully accounted for by inhibition of Ca 2ϩ influx through VOCCs (Takahashi et al., 1996; Powell et al., 2000) .
Mechanism of exocytotic facilitation by AngII
At concentrations of 10 nM or higher, the inhibitory effect of AngII on secretion was overcome, and exocytosis was facilitated. Potentiation of secretion involved activation of PLC, Ca 2ϩ mobilization, and PKC and was independent of the inhibitory pathway. It is well known that GPCR-regulated PLC-␤(1-4) isoenzymes may be activated by ␣-subunits of G q -proteins or with less potency by G␤␥-subunits of numerous G-proteins, including G i /o (Morris and Scarlata, 1997) . The transduction pathway involved in facilitation of exocytosis did not involve the G i /o -coupled AT1R because PTX had no significant effects on AngII-induced Ca 2ϩ mobilization, nor did it attenuate potentiation of exocytosis. Therefore, the AngII receptors mediating facilitation likely correspond to the G q -protein-coupled AT1Rs described previously (Plevin and Boarder, 1988) .
The mechanism underlying agonist-dependent facilitation of exocytosis was found to be dependent on a rise in [Ca 2ϩ ] i . Results from this and other studies showed that the rise in [Ca 2ϩ ] i was attributable to release from intracellular stores and influx across the plasma membrane (Cheek et al., 1993a) . Elevated [Ca 2ϩ ] i has been shown to enhance ⌬C m by increasing the RRP Smith et al., 1998) . Interestingly, in this study we found that caffeine-induced rises in [Ca 2ϩ ] i were not as effective as AngII in potentiating stimulus-evoked exocytosis. The discrepancy may arise from differences in the location of the two Ca 2ϩ signals with regard to the secretory apparatus because the agonist would preferentially activate IP 3 -sensitive stores whereas caffeine activates ryanodine-sensitive stores (Berridge, 1998) . Chromaffin cells, like neurons, are known to possess independent IP 3 -sensitive and caffeine-sensitive stores that are localized to different compartments of the cell (Cheek et al., 1991 (Cheek et al., , 1993a Koizumi et al., 1999) .
Activation of PLC by AT1R will also lead to production of diacylglycerol, which regulates at least two families of proteins known to modulate exocytosis directly, namely PKC and Munc-13 (Hori et al., 1999) , as well as noncapacitative Ca 2ϩ entry pathways (Hofmann et al., 1999) . Evidence in support of a role for PKC in AngII facilitation of stimulus-evoked exocytosis was shown by the use of two different inhibitors. The PKC-dependent facilitation of exocytosis appeared to require a rise in Ca 2ϩ because it was not observed in CPA-treated cells. This is consistent with the known properties of conventional PKC isoforms, which require both diacylglycerol and Ca 2ϩ for activation (Newton and Johnson, 1998) . Note, however, that at concentrations of BIS that are reported to be selective for PKC, AngII-induced facilitation was not abolished, indicating that Ca 2ϩ -dependent proteins other than PKC are also involved. Activity-dependent potentiation of secretion is also reported to be mediated by Ca 2ϩ and PKC and to be quantitatively comparable to the potentiation observed with PMA (Smith et al., 1998) . We found that PMA was less effective than AngII in facilitating exocytosis, suggesting that different or additional effectors are involved in agonist-versus activity-dependent facilitation.
We can conclude from these studies that activation of Ca 2ϩ -mobilizing AT1Rs will facilitate exocytosis through both Ca 2ϩ -and PKC-dependent mechanisms. At present the molecular targets in the secretory pathway that are subject to modulation are unknown. However, considering what is known about compartmentalization of signaling molecules and the processes underlying stimulus-evoked exocytosis, several possibilities arise. Ca 2ϩ released from IP 3 -sensitive stores may act locally to produce actin disassembly through activation of Ca 2ϩ -sensitive actin-severing proteins and thereby promote vesicle recruitment from the reserve pool to the RRP (Zhang et al., 1995) . Additionally, store-released Ca 2ϩ may diffuse toward the plasma membrane and sum with incoming Ca 2ϩ to promote exocytosis. Activation of Ca 2ϩ entry at the plasma membrane may trigger fusion of vesicles docked close to the receptor-operated calcium channels or promote vesicle priming through effects on Ca 2ϩ -binding proteins such as DOC2, Rabphilin, or CAPS (Benfenati et al., 1999; Elhamdani et al., 1999) . Additionally, generation of diacylglycerol at the plasma membrane may increase vesicle docking and priming by activation of PKC and (1) phosphorylation of cytoskeletal proteins controlling vesicle recruitment to the RRP (Vitale et al., 1995) and/or (2) phosphorylation of proteins that regulate SNARE complex formation (Turner et al., 1999) . Diacylglycerol may also activate Munc-13 directly to regulate SNARE complex formation (Hori et al., 1999) . Interestingly, a pathway facilitating exocytosis composed of G q , PLC-␤, and UNC-13 has recently been described in Caenorhabditis elegans (Lackner et al., 1999) . Molecular studies coupled with high-resolution imaging will be needed to discern which of these mechanisms is involved in AngII-dependent facilitation and whether the same signaling cascades are activated by other Ca 2ϩ -mobilizing GPCRs.
Physiological significance and implications of bimodal regulation of secretion
AngII is produced both in the blood and, independently, in the adrenal (Bottari et al., 1993) . Subnanomolar levels of circulating AngII are reached in certain physiological states such as dehydration (Belles et al., 1988) . Our results suggest that they could act to inhibit catecholamine secretion as part of a regulatory feedback loop. The concentrations of AngII required to increase catecholamine release (EC 50 3.4 nM) are less likely to be reached in plasma under steady-state physiological conditions but would be generated locally in the adrenal and contribute to clinical conditions such as hypertension (Francis, 1988) or responses to severe hemorrhage (Gupta et al., 1995; Ponchon and Elghozi, 1997) .
Coupling of AT1Rs to multiple G-proteins has been reported previously (Richards et al., 1999) and is relatively common among GPCRs (Gudermann et al., 1996) . Earlier studies have identified and characterized the selectivity of receptor G-protein-effector coupling or the diversity of effectors regulated by a single receptor subtype (Hille, 1994; Delmas et al., 1998) . AT1R activation of multiple transduction pathways is known to be necessary for coordination of short-term and long-term changes in neuronal function (Richards et al., 1999) . In this study we have shown that one function of AT1R coupling to diverse G-proteins is to produce bimodal regulation of exocytosis, thereby allowing a chromaffin cell to adapt rapidly its secretory output to fluctuating levels of AngII. A similarly complex regulation of hormone release by AngII has been reported in anterior pituitary cells (Enjalbert et al., 1986; Crawford et al., 1992) and adrenal glomerulosa cells (Kojima et al., 1986) . Thus the potential for bimodal regulation of secretion may be a general feature of AT1Rs and possibly other members of the GPCR superfamily.
